Login / Signup

Legacy lessons from the COVID-19 era to improve trial participation and retention: Views from trial participants, PPIE contributors and trial staff across the NIHR portfolio.

Heather LeggettKaren Vinall-CollierJulia CsikarSophy BarberRachel Margaret CarrAmrit BhattiSue Pavitt
Published in: PloS one (2024)
Our findings highlight a number of ways to future proof trial delivery against future pandemics or disruptions such as offering online options to participate in research, ensuring consistent communication between participants and the research team, making sure participants feel fully informed and the continued reassurance of safety in the clinical setting.
Keyphrases
  • phase iii
  • study protocol
  • phase ii
  • clinical trial
  • sars cov
  • coronavirus disease
  • current status
  • randomized controlled trial
  • open label
  • physical activity
  • social media
  • double blind